---
title: "Litigation, Battery Launches and Biotech Research Drive Small-Cap Week"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300554638.md"
description: "RELY.US faces litigation after Q1 revenue miss, XPON.US launches energy storage products, and SRZN.US publishes biotech research amid small-cap volatility. AVT.US, GPAK.US, CCOI.US, BDTX.US, CORT.US, and AIQD.US report strategic developments."
datetime: "2026-09-30T10:14:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300554638.md)
  - [en](https://longbridge.com/en/news/300554638.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300554638.md)
generator: "portal-rs"
---

# Litigation, Battery Launches and Biotech Research Drive Small-Cap Week

Small-cap stocks delivered divergent catalysts this week. RELY.US (RELY.US) faced shareholder litigation after Q1 2026 revenue missed estimates by $4.78 million, triggering volatility. XPON.US (XPON.US) countered with momentum, presenting its Edge lithium-ion battery system at Noble Capital's June 12 conference to target oil and gas microgrids. Biotech players SRZN.US (SRZN.US) and BDTX.US (BDTX.US) advanced pipelines—SRZN published Wnt pathway research in eLife on June 12 while BDTX progressed MasterKey oncology therapies. AVT.US (AVT.US) strengthened AI commercialization through a June 7 partnership with the University of Hong Kong. GPAK.US (GPAK.US) expanded esports events in Pakistan, CCOI.US (CCOI.US) maintained global network infrastructure operations, and CORT.US (CORT.US) continued cortisol-focused drug development. New ETF AIQD.US (AIQD.US) drew attention as an AI-themed investment vehicle.

### Related Stocks

- [GPAK.US](https://longbridge.com/en/quote/GPAK.US.md)
- [AIQD.US](https://longbridge.com/en/quote/AIQD.US.md)
- [XPON.US](https://longbridge.com/en/quote/XPON.US.md)
- [RELY.US](https://longbridge.com/en/quote/RELY.US.md)
- [CCOI.US](https://longbridge.com/en/quote/CCOI.US.md)
- [BDTX.US](https://longbridge.com/en/quote/BDTX.US.md)
- [CORT.US](https://longbridge.com/en/quote/CORT.US.md)
- [AVT.US](https://longbridge.com/en/quote/AVT.US.md)
- [SRZN.US](https://longbridge.com/en/quote/SRZN.US.md)

## Related News & Research

- [Corcept Therapeutics (NASDAQ:CORT) Insider Sells $967,461.30 in Stock](https://longbridge.com/en/news/300979124.md)
- [Corcept Endocrinology President Sean Maduck disposes of USD 2.89 million in Corcept Therapeutics shares](https://longbridge.com/en/news/300975494.md)
- [Surrozen says FDA clears IND for SZN-8141 diabetic macular edema trial](https://longbridge.com/en/news/300788834.md)
- [Visa Stock And Two Payment Plays Tied To Fed Trust Questions](https://longbridge.com/en/news/300866681.md)
- [Remitly Global Doesn't Pay a Dividend and Constantly Dilutes Shareholders. Here's Why I'd Still Buy and Hold It Forever.](https://longbridge.com/en/news/300193947.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**